Relative bioavailability study with Abediterol administered via three different inhalation devices in Healthy Volunteers.

Trial Identifier: D6541C00001
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04199598
Start Date: January 2020
Primary Completion Date: April 2020
Study Completion Date: April 2020
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050